Skip to content

Intrathecal Pethidine Plus Dexamethasone for Distal Lower Orthopedic Surgeries

Comparing the Analgesic Properties of Intrathecal Pethidine Plus Dexamethasone Versus Intrathecal Bupivacaine Alone for Distal Lower Extremity Orthopedic Surgeries: A Randomized Comparative Study.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05303311
Enrollment
46
Registered
2022-03-31
Start date
2022-01-15
Completion date
2024-03-15
Last updated
2024-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Bupivacaine is commonly used as a sole agent for spinal anesthesia unlike pethidine. Pethidine (meperidine) is a unique opioid. In addition to its analgesic activity, it also has significant local anesthetic activity. This property enables it to be used as the sole agent for spinal anesthesia

Detailed description

pethidine compared favorably with bupivacaine as the sole anesthetic agent, providing excellent conditions for lower abdominal and pelvic surgery. Some studies showed that intrathecal pethidine has short motor recovery and prolonged postoperative analgesia in comparison to intrathecal bupivacaine. The side effects of pethidine in spinal anesthesia are pruritus nausea, vomiting and respiratory depression. A dose of 1mg/kg intrathecal pethidine provides surgical anesthesia .However, its effects are not widely available in recent studies. Dexamethasone is used as an adjuvant to local anesthetic during spinal anesthesia and other techniques of regional anesthesia, it reduces pain and prolongs the duration of post-operative analgesia. It was shown that intrathecal dexamethasone reduces the complications of spinal anesthesia such as arterial hypotension, nausea, vomiting and shivering. The investigators suppose that addition of intrathecal dexamethasone to pethidine may be a better alternative to intrathecal bupivacaine during spinal anesthesia for lower extremity orthopedic surgery with better outcome and less side effects

Interventions

DRUGBupivacaine Hydrochloride

intrathecal injection of bupivacaine alone

Intrathecal injection of pethidine plus dexamethasone

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient acceptance. * Patients scheduled for lower extremity orthopedic surgery * Both sex * Patient's age \>18 years. * Patients with American Society of Anaesthesia (ASA)physical status I, II.

Exclusion criteria

* Patient's age ≤18 years. * Uncooperative patients and patients with psychological problems. * Patients with contraindications to spinal anesthesia. * Patients with contraindications to bupivacaine or dexamethasone or pethidine. * Patients with ASA physical status III and IV. * Morbid obesity (BMI \>35).

Design outcomes

Primary

MeasureTime frameDescription
The Time of the first need for Rescue Analgesia24 hours postoperativethe time from the end of the intrathecal injection of the study drugs to the first report of pain that reached NRS 4 as described by the patient.

Secondary

MeasureTime frameDescription
Intraoperative changes in the blood pressure measurements (The incidence of hypotension )duration of the procedureThe incidence of hypotension defined as the mean arterial blood pressure decreased by \> 20 % from its value before intrathecal injection of the study drugs
Intraoperative changes in the heart rate measurements (The incidence of bradycardia)duration of the procedurebradycardia defined as the reduction of heart rate by \> 20% of the basal reading.
The onset of the sensory blockduration of the procedureThe sensory level was checked using the pinprick technique every min for 10 min then at 2-min intervals until a constant block was obtained
The onset of the motor blockduration of the procedureThe Motor Block was checked using Modified Bromage Score Bromage 0 means full movement of the hip, knee, and ankle, Bromage 1 means loss of the ability to raise the leg against gravity but able to bend the knee and the ankle joints, Bromage 2 lost the ability to flex the hip and knee joints but preserved flexion of the ankle, Bromage 3 lost the ability to flex the hip, knee, and ankle joints but preserved movement of the toes, Bromage 4 indicates full paralysis of the legs. every min for 10 min then at 2-min intervals until a Bromage score 4 was obtained
The time of regression of sensory block to the 5th lumbar dermatomeUp to 12 hours postoperativeThe sensory level was checked using the pinprick technique every 15 min until sensations were gained back to the 5th lumbar dermatome
The time of regression of motor block to full motor function Bromage score 0.Up to 12 hours postoperativeThe Motor Block was checked using Modified Bromage Score every 15 min until full motor function was restored. Bromage score 0...... Modified Bromage Score: Bromage 0 means full movement of the hip, knee, and ankle, Bromage 1 means loss of the ability to raise the leg against gravity but able to bend the knee and the ankle joints, Bromage 2 lost the ability to flex the hip and knee joints but preserved flexion of the ankle, Bromage 3 lost the ability to flex the hip, knee, and ankle joints but preserved movement of the toes, Bromage 4 indicates full paralysis of the legs.
The incidence of perioperative adverse eventsduration of the procedure and 24 hours postoperativeAssess the frequency of perioperative nausea, vomiting, sedation, shivering, pruritis, and respiratory depression.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026